Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TAK Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | ABBV AbbVie |
|---|---|---|
| Price | $18.70 +0.5% | $263.04 +0.5% |
| StockIQ Score | 63C+ Moderate Risk: Medium | 54C- Moderate Risk: Medium |
| Technical | 73B | 69B- |
| Fundamental | — | 56C |
| Growth | — | 34F |
| Fair Value | — | 33F |
| News | 44D | 86A |
| Quality | — | 47D+ |
| Risk | 50C- | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Takeda (TAK) scores higher than AbbVie (ABBV) on the investor metric (63 vs 54) and on the technical metric (73 vs 69). AbbVie is the only one with reported fundamental (56), growth (34) and valuation (33) scores. Both have a moderate rating.
